Nature Immunology
Learning from cancer mutations
Nature Immunology, Published online: 01 March 2024; doi:10.1038/s41590-024-01783-3Learning from cancer mutations
Nature Immunology, Published online: 01 March 2024; doi:10.1038/s41590-024-01783-3Learning from cancer mutations
Nature Immunology, Published online: 01 March 2024; doi:10.1038/s41590-024-01759-3Drivers of persistent symptoms after acute COVID-19 remain largely unknown. Alterations in immune function, iron homeostasis and dysregulated erythropoie…
Nature Immunology, Published online: 01 March 2024; doi:10.1038/s41590-024-01790-4As part of Women’s History Month, we are celebrating the contributions of women who stand at the crossroads of immunology and neurobiology.
Nature Immunology, Published online: 27 February 2024; doi:10.1038/s41590-024-01768-2Schäfer et al. discuss the application of computational methods that integrate single-cell and spatial multi-omics with existing biological knowledge …
Nature Immunology, Published online: 26 February 2024; doi:10.1038/s41590-024-01756-6Linnerbauer and colleagues find that HB-EGF produced by reactive astrocytes is protective during autoimmune neuroinflammation, but epigenetically supp…
Nature Immunology, Published online: 26 February 2024; doi:10.1038/s41590-024-01765-5A study identifies an increase in the tissue-protective factor HB-EGF during the initial stage of multiple sclerosis (MS), which is actively turned of…
Nature Immunology, Published online: 23 February 2024; doi:10.1038/s41590-024-01774-4Here the authors use positron emission tomography to visualize fibroblasts in patients with arthritis and combined with spatial transcriptomic data sh…
Nature Immunology, Published online: 21 February 2024; doi:10.1038/s41590-024-01775-3Bacillus Calmette–Guérin (BCG) is the only available vaccine against tuberculosis. As well as being an effective vaccine against tuberculosis, BCG als…
Nature Immunology, Published online: 20 February 2024; doi:10.1038/s41590-024-01744-wIn this study, we developed an adenoviral-vectored vaccine that targets the spike protein of BA.5 Omicron SARS-CoV-2. When nasally delivered in mice a…
Nature Immunology, Published online: 20 February 2024; doi:10.1038/s41590-024-01744-wIn this study, we developed an adenoviral-vectored vaccine that targets the spike protein of BA.5 Omicron SARS-CoV-2. When nasally delivered in mice a…